Literature DB >> 8384076

Cytogenetic studies on human liver cancer cell lines.

H L Chen1, T S Chiu, P J Chen, D S Chen.   

Abstract

Karyotyping of human liver cancer cell lines and chromosome in situ hybridization of hepatitis B virus (HBV) DNA was performed in order to elucidate the possible mechanism of hepatocarcinogenesis from evidence of chromosomal changes and HBV integration patterns. HepG2-2 and HepG2-5 cell lines were HepG2 cells experimentally transfected with HBV DNA; the HCC36 cell line was derived from a hepatocellular carcinoma containing integrated HBV DNA from a Taiwanese patient. HepG2 cells, a hepatoblastoma cell line without HBV DNA integration, served as negative control. In HepG2-2, HepG2-5, and HCC36 cells, multiple integrations of HBV DNA were observed by in situ hybridization and hybridization signals occurred preferentially on certain chromosomes: 2, 5, 10, 11, 18; 7, 10, 13, 17, 18; and 4, 6, 11, 12q+, 18; respectively. In addition, a strong correlation between chromosomal changes and HBV integration was noticed in HCC36 cells, especially at chromosome 12q+.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8384076     DOI: 10.1016/0165-4608(93)90227-d

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  6 in total

1.  Effects of hepatitis B virus infection on human sperm chromosomes.

Authors:  Jian-Min Huang; Tian-Hua Huang; Huan-Ying Qiu; Xiao-Wu Fang; Tian-Gang Zhuang; Hong-Xi Liu; Yong-Hua Wang; Li-Zhi Deng; Jie-Wen Qiu
Journal:  World J Gastroenterol       Date:  2003-04       Impact factor: 5.742

2.  Trisomy 1 and 8 occur frequently in hepatocellular carcinoma but not in liver cell adenoma and focal nodular hyperplasia. A fluorescence in situ hybridization study.

Authors:  A Nasarek; M Werner; M Nolte; J Klempnauer; A Georgii
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

3.  New human hepatocellular carcinoma (HCC) cell line with highly metastatic potential (MHCC97) and its expressions of the factors associated with metastasis.

Authors:  J Tian; Z Y Tang; S L Ye; Y K Liu; Z Y Lin; J Chen; Q Xue
Journal:  Br J Cancer       Date:  1999-11       Impact factor: 7.640

4.  Haplotype-resolved and integrated genome analysis of the cancer cell line HepG2.

Authors:  Bo Zhou; Steve S Ho; Stephanie U Greer; Noah Spies; John M Bell; Xianglong Zhang; Xiaowei Zhu; Joseph G Arthur; Seunggyu Byeon; Reenal Pattni; Ishan Saha; Yiling Huang; Giltae Song; Dimitri Perrin; Wing H Wong; Hanlee P Ji; Alexej Abyzov; Alexander E Urban
Journal:  Nucleic Acids Res       Date:  2019-05-07       Impact factor: 16.971

Review 5.  The Curious Case of the HepG2 Cell Line: 40 Years of Expertise.

Authors:  Viktoriia A Arzumanian; Olga I Kiseleva; Ekaterina V Poverennaya
Journal:  Int J Mol Sci       Date:  2021-12-04       Impact factor: 5.923

6.  Inhibition of VEGF165/VEGFR2-dependent signaling by LECT2 suppresses hepatocellular carcinoma angiogenesis.

Authors:  Chi-Kuan Chen; Wen-Hsuan Yu; Tsu-Yao Cheng; Min-Wei Chen; Chia-Yi Su; Yi-Chieh Yang; Tsang-Chih Kuo; Ming-Tsan Lin; Ya-Chi Huang; Michael Hsiao; Kuo-Tai Hua; Mien-Chie Hung; Min-Liang Kuo
Journal:  Sci Rep       Date:  2016-08-10       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.